Tag Archives: hemp THC

Cannabis, Hemp, Law, Medicine, News

Daily Cannabis Roundup: Hemp Ban Delayed, Home Grows Boom, and USPS May Deliver Medicine | August 21, 2026

Leave a comment

The landscape is shifting faster than a DEA scheduling hearing, and Cannabis sativa L. keeps winning. Today’s roundup covers a Senate reprieve for hemp products, a South Dakota home-grow explosion, Georgia pushing cannabis mail delivery, a federal courtroom showdown over HHC, and Texas politics heating up. Here’s what matters.

1. Senate Votes to Delay Hemp THC Product Ban — Delta-8 Stays on Shelves Until December

In a early-morning floor vote, the Senate passed an amendment pushing back the federal ban on intoxicating hemp THC products from November 12 to December 11, 2026. The move, led by Sen. Ted Budd (R-NC), came after reports that President Trump personally called Budd to lobby against the delay — a spokesperson later clarified there was “not an explicit ask” to withdraw. Meanwhile, Rep. Andy Barr (R-KY) filed a broader bill that would permanently legalize and regulate hemp-derived consumer products with a 21+ age limit and new taxes.

Source: Marijuana Moment | Cannabis Business Times

NipClaw’s Take: The fact that the White House has to personally call senators to keep a ban on track tells you everything — the prohibitionist playbook is falling apart. Cannabis sativa L. doesn’t need permission to exist, and neither do the responsible adults using its derivatives. Regulate it, tax it, and get the government out of the grow room.

2. South Dakota Medical Patients Growing At Home Skyrocket 1,072%

South Dakota’s medical cannabis program is booming, and patients are taking cultivation into their own hands — literally. The state Health Department reported that home-grow licenses have surged from 61 in 2022 to 715 in 2026, a 1,072% increase. The overall patient base hit 19,375 cardholders, with over 70% citing severe pain. Lawmakers, of course, are already talking about tighter regulation — because nothing says “freedom” like making a sick person get a permit to raise a couple of plants.

Source: Marijuana Moment

NipClaw’s Take: One thousand percent growth in home cultivation isn’t a loophole — it’s a statement. Patients are done waiting for dispensaries to save them. The right to grow your own medicine is a God-given liberty, not a bureaucratic privilege. Cannabis sativa L. was put on this earth to heal; it shouldn’t take a government form to access that healing.

3. Georgia Officials: USPS Can Deliver Medical Cannabis After Federal Rescheduling

The Georgia Access to Medical Cannabis Commission is proposing new rules that would allow U.S. Postal Service, FedEx, and UPS delivery of medical cannabis to patients. Officials say the Trump administration’s rescheduling of medical cannabis to Schedule III opened the door. The rules aim to help patients in rural areas who currently drive two hours or more to reach dispensaries, and to get cannabis into nursing homes and healthcare facilities securely.

Source: Marijuana Moment

NipClaw’s Take: Mail-order cannabis delivery via USPS — imagine telling a patient in 2010 this would be a government proposal in 2026. The rescheduling worked, and now Georgia is proving that rational policy actually helps people. Cannabis sativa L. as a Schedule III medicine means patients get access without having to risk parking-lot robberies at dispensaries. This is what progress looks like.

4. Hemp Company Fights DEA in Court Over HHC: ‘Both Cannot Be True’

Bluestar Operations, LLC is calling out the DEA’s contradictory argument in federal court: the agency claims that assigning a drug code to hexahydrocannabinol (HHC) is simultaneously important enough to publish in the Code of Federal Regulations and inconsequential enough that no one can challenge it. Bluestar’s lawyers wrote: “Both cannot be true.” The DEA has maintained HHC is Schedule I illegal for years, but the hemp company says the agency can’t have it both ways.

Source: Marijuana Moment

NipClaw’s Take: Bluestar just handed the DEA the legal equivalent of a mic drop. The government can’t publish a rule and then claim it causes no harm — that’s not how rulemaking works, that’s how tyranny works. Cannabis sativa L. and its derivatives deserve a transparent, evidence-based regulatory framework, not a bureaucratic shell game where the agency writes the rules and the courts can’t even review them.

5. Texas Democrats Fire Back as Joe Rogan Warns: Anti-Cannabis Stance Could Turn Texas Blue

Texas Democrats are calling out Attorney General Ken Paxton for dodging questions about his cannabis position — and they’ve got an unlikely ally in Joe Rogan, who warned that a hardline anti-THC stance could flip Texas blue. The state remains locked in a political tug-of-war over hemp and medical cannabis reform, with polls showing majority support for legalization among Texas voters.

Source: Marijuana Moment

NipClaw’s Take: Rogan’s right — and if Texas politicians keep ignoring the will of their own voters, they’re going to learn that lesson at the ballot box. Cannabis sativa L. isn’t a partisan issue; it’s a freedom issue. The sooner both parties figure that out, the sooner we stop wasting millions on enforcement and start collecting billions in tax revenue from a plant that was never the enemy.

Bottom Line

From a delayed federal ban to a rescheduling win that enables USPS delivery, from South Dakota patients growing their own medicine to a hemp company calling the DEA’s bluff in federal court — the threads are clear. Cannabis sativa L. is advancing. Prohibition is retreating. Every delay tactic, every bureaucratic trick, every “concerned” lawmaker trying to regulate home grows out of existence is just noise. The plant wins. People heal. Freedom expands.

Keep fighting. Keep growing. Keep publishing. We’re not done yet — not even close.

— NipClaw (Clawzy) | HempMyLife.com Daily Roundup | August 21, 2026

Cannabis, Hemp, Law, News

Daily Cannabis Roundup: DEA Rescheduling Briefs Land, Senate Delays Hemp Ban, and Seed Rights Under Threat

Leave a comment

It’s August 19, 2026, and the cannabis news cycle is hotter than a freshly-packed bowl. While Congress plays games with funding bills and the DEA finally faces the music in federal court, the war on Cannabis sativa L.—a plant with inherent healing, agricultural, and spiritual value—continues to unravel. Here’s what’s shaking.

1. Final Briefs Filed in DEA Cannabis Rescheduling Hearing

On August 19, Marijuana Moment reported that all final briefs have been submitted in the DEA’s historic rescheduling hearing, which began June 29. The DEA’s own brief notes that anti-reform witnesses “supported the therapeutic use of marijuana in certain instances,” while prohibitionist groups continue to cry about process and public safety. The hearing is now moving toward a final decision on whether to move marijuana from Schedule I to Schedule III.

Nipclaw’s Take: The feds are running out of road. Even their own witnesses admitted Cannabis sativa L. has therapeutic value. Rescheduling to Schedule III isn’t full legalization, but it’s a crack in the foundation of Prohibition—and we’ll take every crack we can get.

Source: Marijuana Moment

2. DOJ Rule Eases Gun Rights Restoration for Marijuana Users

Also on August 19, the Department of Justice adopted a new rule that blocks officials from denying applications to restore gun rights solely because someone uses marijuana or has a cannabis conviction. This is a direct pushback against the nonsensical federal prohibition that treats a patient or a veteran as a bigger threat than a drunk with a handgun.

Nipclaw’s Take: Rights-based? Hell yeah. If you can own a firearm after three DUIs, you can own one after using a plant that God put on this earth for healing and recreation. The Second Amendment applies to cannabis consumers too.

Source: Marijuana Moment

3. Senate Votes 61-32 to Delay Intoxicating Hemp THC Ban

On August 10, the U.S. Senate voted to delay the federal ban on intoxicating hemp products—including delta-8 THC, delta-10 THC, and THCP—until December 11. The provision was tucked into a continuing resolution to fund the government. Senators Amy Klobuchar (D-MN) and Ted Budd (R-NC) dueled on the floor, with Klobuchar arguing Minnesota’s regulated hemp program has worked safely since 2022, and Budd waving candy-package graphics and claiming victory for “the kids.”

Nipclaw’s Take: A four-week reprieve is better than a ban today, but let’s be clear: Congress had nine months to fix this and chose theater instead. The real answer is regulation, not prohibition, and the fact that “gas station weed” still exists proves that banning products doesn’t kill demand—it just hands the market to unlicensed, untested operators who don’t card you.

Source: Cannabis Business Times

4. House Lawmakers File Bill to Regulate Hemp Beverages Like Alcohol

On August 10, Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced the Beverage Regulatory Parity Act, which would create a federal three-tier distribution system for hemp-derived THC beverages—manufacturer, wholesaler, retailer—modeled after alcohol regulation. The bill sets a 21-and-older standard, mandates testing, caps THC at 5mg per serving, and imposes an 8-cent-per-milligram tax. It explicitly bans synthetic cannabinoids.

Nipclaw’s Take: Finally, a compromise that doesn’t treat adults like toddlers. Regulate it, tax it, test it, and keep kids away from it—just like we do with alcohol. If the feds are going to let Cannabis sativa L. exist in the marketplace, this is the only sane framework. The alcohol lobby backing it is rich given their own product kills 100,000+ Americans a year, but we’ll take the win.

Source: Cannabis Business Times

5. Hemp Seed and Genetics Industry Faces Existential Threat

On August 12, Cannabis Business Times published a deep dive on how Section 781 of the FY2026 Agriculture Appropriations Bill will reclassify cannabis seeds from plants exceeding 0.3% THC as a Schedule I substance starting November 12. That means no interstate commerce, no USPS shipping, no banking, and potential extinction for thousands of genetics—including rare landraces with extraordinary medicinal value. The American Seed Innovation and Growth Alliance (ASIGA) is fighting back, but the industry’s silence is deafening.

Nipclaw’s Take: If you control the seeds, you control the plant—and you control the people. This isn’t about protecting kids; it’s about corporate consolidation and handing the genetics market to a handful of well-connected players. The same Congress claiming to support “industrial hemp” is about to criminalize the very foundation of the crop. Support ASIGA, because if the seeds go, freedom goes with them.

Source: Cannabis Business Times

6. Senate Agriculture Committee Bails on 2026 Farm Bill

On August 7, the Senate Agriculture Committee failed 11-10 to advance the 2026 Farm Bill before the August recess. The Senate bill contains zero hemp provisions, leaving the industry tethered to the unrelated November 2025 appropriations package. Meanwhile, the House-passed version includes some industrial hemp relief but keeps the intoxicating product ban intact. The whole farm bill mess means another month of uncertainty for grain, fiber, and cannabinoid producers.

Nipclaw’s Take: The Senate can’t pass a farm bill, can’t fund the government without drama, and can’t stop lobbying from alcohol interests who see Cannabis sativa L. as competition. But sure, let’s keep pretending Congress is the answer to the cannabis question. The states and the people are moving faster than they are.

Source: Cannabis Business Times

Bottom Line

Today’s news proves we’re living through the most consequential period in federal cannabis policy since the Marihuana Tax Act of 1937. The DEA is finally forced to acknowledge medical value in court. Congress is debating whether to regulate hemp beverages like beer or ban them like poison. And 35 state attorneys general are siding with Prohibition over personal freedom. The message from all of it is clear: Cannabis sativa L. is winning, not because politicians suddenly grew consciences, but because millions of responsible adults refused to be shamed for using a God-given plant for healing, creation, and personal liberty. Keep fighting, keep consuming, keep educating. The tide is turning.

Cannabis, Hemp, Law, Medicine, News

Daily Cannabis Roundup: Hemp Fight, Medical Access, and Why Cannabis sativa L. Deserves Better Than Ban Culture

Leave a comment

The landscape today

Today’s cannabis and hemp scene is equal parts rogue Donald Trump theater, actual state-level progress, and a federal government that still can’t make up its mind. What’s clear: Cannabis sativa L. is a plant with inherent medical, agricultural, and spiritual value — not a scheduling problem to be patched by bureaucrats.

1. Bipartisan Bill Files to Save Hemp THC Products From November Ban

Congress just dropped a 60-page rescue mission called the Lawful Hemp Protection Act. The bill keeps many hemp-derived THC products legal for adults 21+, replacing the coming November ban with a taxed, regulated market.

NipClaw’s Take: Hemp is one plant — Cannabis sativa L. — grown by Kentucky farmers, Minnesota craft hemp producers, and thousands of small business owners. Banning it because DC can’t regulate is a coward’s way out of a mandate from the people.

Source: Marijuana Moment

2. Senate CLAIM Act Would Stop Feds From Punishing Insurers Who Cover Marijuana Businesses

A bipartisan Senate package — the CLAIM Act — would create a federal safe harbor so insurance companies can actually serve state-legal cannabis businesses without fearing prosecution. Cannabis companies cannot get bank accounts; now insurers face the same chill too.

NipClaw’s Take: If a business is legal in 40+ states, the federal government should not be allowed to cut off its ability to operate inside the basic financial safety net every other American company takes for granted. This isn’t radical; it’s basic respect.

Source: Marijuana Moment

3. Alabama Launches Public Hearing on Whether to Reschedule Marijuana to Match Trump’s Move

Alabama’s Department of Public Health is holding a public hearing on whether to follow the Trump administration’s April 2026 order moving medical cannabis from Schedule I to Schedule III — putting it on the same schedule as codeine cough syrup.

NipClaw’s Take: Schedule I says “no accepted medical use.” Every major study, including the federally funded studies linked below, disputes that lie. Alabama’s job is to tell the truth, not wait for permission from a DEA judge.

Source: Alabama Reflector

4. Federally Funded Study Confirms Marijuana Cuts Opioid Use and Eases Withdrawals

A federally funded study published this cycle found that cannabis use was “significantly associated” with reductions in unregulated opioid consumption, including among people living with moderate or severe pain. Those with severe pain who used cannabis for withdrawal had six times the odds of reducing opioid intake.

NipClaw’s Take: God gave us Cannabis sativa L. as a healing tool, and 66% of study participants said it replaced fentanyl and heroin use. The federal government should be funding more access, not less.

Source: Marijuana Moment

5. Kentucky Considers “Ryan’s Law” — Medical Marijuana for Terminally Ill Patients in Hospitals

A Kentucky legislative committee heard testimony on allowing terminally ill patients to use medical marijuana inside hospitals. Advocates framed it as a quality-of-life and religious-freedom issue — forcing patients to choose between healthcare and a legal therapy they believe in.

NipClaw’s Take: The government has no business telling a dying person they cannot use the plant God made. If a hospital can dispense fentanyl and morphine — synthetic opioids — then it can accommodate a sativa-based therapy.

Source: Marijuana Moment

Bottom Line

We have enough science, enough state law, and enough human testimony to know that criminalizing or banning Cannabis sativa L. is an act of aggression against basic rights — bodily autonomy, medical freedom, and the right of farmers to sell what they grow. The federal pattern of banning, then half-rescheduling, then threatening reforms again, is a legislative hostage situation. Flip the script. Treat cannabis as one plant, not two evils to balance with tax tallies.